Erdem GU - Search Results

1

Comparative study of receptor discordance between primary and corresponding metastatic lesions in breast cancer.

Erdem GU, Altundag K, Ozdemir NY, Sahin S, Demirci NS, Karatas F, Bozkaya Y, Aytekin A, Tasdemir V, Aslan AC, Sever AR, Zengin N. Erdem GU, et al. J BUON. 2017 Mar-Apr;22(2):365-376. J BUON. 2017. PMID: 28534357 Free article.

2

A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.

Erdem GU, Sendur MA, Ozdemir NY, Yazıcı O, Zengin N. Erdem GU, et al. Curr Med Res Opin. 2015 Apr;31(4):743-56. doi: 10.1185/03007995.2015.1018988. Epub 2015 Mar 17. Curr Med Res Opin. 2015. PMID: 25690490 Review.

3

Is it Time to Change the Control Placebo Arms in Phase III Trials of Metastatic Castration Resistant Prostate Cancer?

Dogan M, Erdem GU, Zengin N. Dogan M, et al. Among authors: erdem gu. Asian Pac J Cancer Prev. 2015;16(14):6167-9. doi: 10.7314/apjcp.2015.16.14.6167. Asian Pac J Cancer Prev. 2015. PMID: 26320514 Free article.

4

A rare case: Hallucination associated with pazopanib.

Demirci NS, Erdem GU, Dogan M, Ozdemir NY, Zengin N. Demirci NS, et al. Among authors: erdem gu. J Cancer Res Ther. 2015 Oct-Dec;11(4):961-2. doi: 10.4103/0973-1482.160919. J Cancer Res Ther. 2015. PMID: 26881556 Free article.

5

Small cell carcinoma of the urinary bladder: changing trends in the current literature.

Erdem GU, Özdemir NY, Demirci NS, Şahin S, Bozkaya Y, Zengin N. Erdem GU, et al. Curr Med Res Opin. 2016 Jun;32(6):1013-21. doi: 10.1185/03007995.2016.1155982. Epub 2016 Mar 17. Curr Med Res Opin. 2016. PMID: 26889739 Review.

6

More data along with further definitions are required.

Sahin S, Erdem GU, Karatas F, Aytekin A, Sever AR, Altundag K. Sahin S, et al. Among authors: erdem gu. Breast. 2016 Dec;30:228-229. doi: 10.1016/j.breast.2016.04.014. Epub 2016 May 24. Breast. 2016. PMID: 27231205 No abstract available.

7

Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.

Karatas F, Erdem GU, Sahin S, Aytekin A, Yuce D, Sever AR, Babacan T, Ates O, Ozisik Y, Altundag K. Karatas F, et al. Among authors: erdem gu. Breast. 2017 Apr;32:237-244. doi: 10.1016/j.breast.2016.05.013. Epub 2016 Jun 16. Breast. 2017. PMID: 27318645

8

Queries for the article entitled "Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases".

Erdem GU, Sahin S, Karatas F, Aytekin A, Demirci NS, Yazilitas D. Erdem GU, et al. Breast. 2017 Dec;36:104-105. doi: 10.1016/j.breast.2016.06.009. Epub 2016 Jun 29. Breast. 2017. PMID: 27368144 No abstract available.

9

Oxaliplatin-induced acute thrombocytopenia.

Erdem GU, Dogan M, Demirci NS, Zengin N. Erdem GU, et al. J Cancer Res Ther. 2016 Apr-Jun;12(2):509-14. doi: 10.4103/0973-1482.154056. J Cancer Res Ther. 2016. PMID: 27461601 Free article. Review.

10

Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach.

Bozkaya Y, Erdem GU, Ozdemir NY, Demirci NS, Hocazade C, Yazıcı O, Zengin N. Bozkaya Y, et al. Among authors: erdem gu. Curr Med Res Opin. 2017 Jan;33(1):109-116. doi: 10.1080/03007995.2016.1239192. Epub 2016 Oct 18. Curr Med Res Opin. 2017. PMID: 27646639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters